Isosorbide mononitrate and preparation technology thereof
A technology of isosorbide dinitrate and drugs, applied in the field of medicine, can solve the problems of large toxic and side effects, easy to repeat, slow onset, etc., achieve the effect of low price, improve heart index, and not suitable for recurrence
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0040] A compound isosorbide mononitrate pharmaceutical composition is characterized in that it is prepared from the following weight ratio raw materials,
[0041] 0.3 parts of isosorbide mononitrate, 25 parts of astragalus, 20 parts of Chuanxiong, 15 parts of antlers, 12 parts of Trichosanthes
[0042] The above composition is prepared into dosage forms such as capsules, tablets, granules, etc. after adding pharmaceutical excipients such as starch or edible cellulose according to the usual pharmaceutical method.
[0043] Preferably, the preparation method of the compound isosorbide mononitrate pharmaceutical composition is: take 0.3g of isosorbide mononitrate, 25g of Astragalus membranaceus, 20g of Chuanxiong, 15g of antlers, and 12g of Trichosanthes trinitrate, and grind them into capsules according to a conventional method. 0.5g, it is a finished product after passing the inspection.
[0044] It is recommended to take the above-mentioned compound isosorbide mononitrate pha...
Embodiment 2
[0065] clinical information
[0066] Select 71 patients with coronary heart disease and angina pectoris and divide them into two groups randomly. The treatment group consisted of 36 cases, including 19 males and 17 females, aged 50 to 74 years, with an average of 61.43±5.21 years, and the course of disease was six months to 15 years. There were 35 cases in the control group, including 17 males and 18 females, aged 49 to 75 years, with an average age of 57.38±5.64 years, and the course of disease was 5 months to 13 years. There was no significant difference in gender, age, and course of disease between the two groups before treatment ( P>0.05), comparable.
[0067] Diagnostic criteria
[0068] Western medicine diagnostic criteria
[0069] Refer to "Suggestions for the Diagnosis and Treatment of Unstable Angina Pectoris" by the Cardiovascular Disease Branch of the Chinese Medical Association.
[0070] Diagnosis and Syndrome Differentiation Standards of TCM
[0071] The TCM ...
Embodiment 3
[0083] typical embodiment
[0084] Qi, 41 years old, male, suffering from rheumatic heart disease and lung disease, paroxysmal angina, often chest tightness, shortness of breath, and waking up in the middle of the night, after taking the compound isosorbide mononitrate preparation of the present invention for one month, angina pectoris, chest tightness, waking up from sleep Only show effect once, through taking three courses for the treatment of (three months), all diseases disappear greatly. Follow up a case by regular visits to and there is no recurrence.
[0085] Sun Mou, 57 years old, female, self-reported stabbing pain in the left chest, sometimes causing pain in the back, dark coating and thready pulse, the syndrome belonged to blood stasis, dark tongue with greasy coating, deep and thready pulse, after taking the compound isosorbide mononitrate of the present invention Three courses of treatment of the preparation recovered from illness, and there was no recurrence in ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com